Literature DB >> 11930006

The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells.

Thomas Pohl1, Raffi Gugasyan, Raelene J Grumont, Andreas Strasser, Donald Metcalf, David Tarlinton, William Sha, David Baltimore, Steve Gerondakis.   

Abstract

Transcription factors NF-kappaB1 and c-Rel, individually dispensable during embryogenesis, serve similar, yet distinct, roles in the function of mature hemopoietic cells. Redundancy among Rel/NF-kappaB family members prompted an examination of the combined roles of c-Rel and NF-kappaB1 by using mice that lack both proteins. Embryonic development and the maturation of hemopoietic progenitors were unaffected in nfkb1(-/-)c-rel(-/-) mice. Peripheral T cell populations developed normally, but follicular, marginal zone, and CD5(+) peritoneal B cell populations all were reduced. In culture, a failure of mitogen-stimulated nfkb1(-/-)c-rel(-/-) B cells to proliferate was caused by a cell cycle defect in early G(1) that prevented growth. In vivo, defects in humoral immunity and splenic architecture seen in nfkb1(-/-) and c-rel(-/-) mice were exacerbated in the double mutant mice. These findings demonstrate that in the B lineage overlapping roles for NF-kappaB1 and c-Rel appear to be restricted to regulating the activation and function of mature cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11930006      PMCID: PMC123679          DOI: 10.1073/pnas.072071599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells.

Authors:  B H Horwitz; M L Scott; S R Cherry; R T Bronson; D Baltimore
Journal:  Immunity       Date:  1997-06       Impact factor: 31.745

Review 2.  Rel/NF-kappaB/IkappaB proteins and cancer.

Authors:  T D Gilmore; M Koedood; K A Piffat; D W White
Journal:  Oncogene       Date:  1996-10-03       Impact factor: 9.867

Review 3.  The immunoglobulin class switch: beyond "accessibility".

Authors:  C M Snapper; K B Marcu; P Zelazowski
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

4.  Requirement for NF-kappaB in osteoclast and B-cell development.

Authors:  G Franzoso; L Carlson; L Xing; L Poljak; E W Shores; K D Brown; A Leonardi; T Tran; B F Boyce; U Siebenlist
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

5.  B cell differentiation and isotype switching is related to division cycle number.

Authors:  P D Hodgkin; J H Lee; A B Lyons
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

6.  The subunit composition of NF-kappa B complexes changes during B-cell development.

Authors:  R J Grumont; S Gerondakis
Journal:  Cell Growth Differ       Date:  1994-12

7.  Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor.

Authors:  S Gerondakis; A Strasser; D Metcalf; G Grigoriadis; J Y Scheerlinck; R J Grumont
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

8.  B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching.

Authors:  C M Snapper; P Zelazowski; F R Rosas; M R Kehry; M Tian; D Baltimore; W C Sha
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

9.  B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells.

Authors:  R J Grumont; I J Rourke; L A O'Reilly; A Strasser; K Miyake; W Sha; S Gerondakis
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

10.  Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs.

Authors:  D Carrasco; F Weih; R Bravo
Journal:  Development       Date:  1994-10       Impact factor: 6.868

View more
  47 in total

1.  Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.

Authors:  Shelby O'Connor; Stuart D Shumway; Ian J Amanna; Colleen E Hayes; Shigeki Miyamoto
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  The NF-κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties.

Authors:  Raffi Gugasyan; Elisha Horat; Sarah A Kinkel; Fiona Ross; George Grigoriadis; Daniel Gray; Meredith O'Keeffe; Stuart P Berzins; Gabrielle T Belz; Raelene J Grumont; Ashish Banerjee; Andreas Strasser; Dale I Godfrey; Philip N Tsichlis; Steve Gerondakis
Journal:  EMBO J       Date:  2011-11-29       Impact factor: 11.598

Review 3.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

4.  A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes.

Authors:  Laurent Verkoczy; Djemel Aït-Azzouzene; Patrick Skog; Annica Märtensson; Julie Lang; Bao Duong; David Nemazee
Journal:  Immunity       Date:  2005-04       Impact factor: 31.745

5.  TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40.

Authors:  Haifa H Jabara; Yu Weng; Tatyana Sannikova; Raif S Geha
Journal:  Int Immunol       Date:  2009-02-19       Impact factor: 4.823

6.  NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency.

Authors:  Laurie T Krug; Christopher M Collins; Lisa M Gargano; Samuel H Speck
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

7.  NF-kappaB1 and c-Rel cooperate to promote the survival of TLR4-activated B cells by neutralizing Bim via distinct mechanisms.

Authors:  Ashish Banerjee; Raelene Grumont; Raffi Gugasyan; Christine White; Andreas Strasser; Steve Gerondakis
Journal:  Blood       Date:  2008-09-19       Impact factor: 22.113

Review 8.  The Paracaspase MALT1.

Authors:  Janna Hachmann; Guy S Salvesen
Journal:  Biochimie       Date:  2015-09-16       Impact factor: 4.079

9.  Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.

Authors:  Ashish Jain; Chi A Ma; Eduardo Lopez-Granados; Gary Means; William Brady; Jordan S Orange; Shuying Liu; Steven Holland; Jonathan M J Derry
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

10.  c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells.

Authors:  Iwao Isomura; Stephanie Palmer; Raelene J Grumont; Karen Bunting; Gerard Hoyne; Nancy Wilkinson; Ashish Banerjee; Anna Proietto; Raffi Gugasyan; Li Wu; Wu Li; Alice McNally; Raymond J Steptoe; Ranjeny Thomas; M Frances Shannon; Steve Gerondakis
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.